ReviewEXCLI journal2026

Efficacy and safety of CTLA-4, PD-1 and LAG-3 immune checkpoint inhibitors as monotherapy and combination therapy in advanced melanoma: A systematic review and meta-analysis.

Osama Omar KhanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.